IJsing radioactively labeled derivatives of lactacystin, the target of Lactacystin was purified from bovine brain extracts and identified as the 20s proteasome [7] . The proreasome is a .bigh molecular weight, multicatalytic protease complex that is responsible for ubiquitin-dcpendent protein degradation within the cel1 (for reviews, see [S-11] ). The proteasome is capable of both complete proteolysis of protein substrates and limited proteolytic processing teading to activation of protein function [IZ] . 
Ac-LLnLal
Structures of lactacystin and a related p-lactone, c/asfo-lactacystin p-lactone, and of the peptide aldehydes used in this study.
The proteasame consists of a multi-subunit catalytic core with a sedimentation coefficient of 205 (the 20s protcasome) that can degrade peptide and certain protein substrates independent of the presence of ATP and ubiquitin and 'capping' subunits that, together with the proteolytitally active core, form the so-called 2% proteasome which is ATP-and ubiquitin-dependent.
Activities of the proteasotne
The 20s proteasome is thought co have at least five distinct catalytic activities. The most firmly established and best characterized of these activities are named the chymotrypsin-like, trypsin-like and peptidyIgIutamylpeptide hydrolyzing (PGPH) activities.
These cleave on the carboxyl side of hydrophobic, basic and acidic residues, respectively. Based on inhibitor, activator, kinetic and genetic studies, these activities appear to arise from separate active sites. Inhibitor studies also provide evidence for the existence of two additional peptidase activities that cleave after amino acid residues wish neutral side chains, which are apparently distinct from the chymotrypsin-like activity. One of these cleaves preferentially after amino acid residues with branched side chains (the BrAAP activity), the other between residuts with the small neutral sidechains .&zine and alaninc (the SNAAP activity) [I3] . There is&idencr to suggest that the BrAAP activity is a major contributor to protein degradation by the proteasome [13] .
Lactacyscin binds to the 205 catalytic core of the protcasome and-inhibits three of its major peptidase activities, the chymotrypsin-like, trypsin-like and PGPH activities, fn O&I [7] . Lactacystin also binds to the proteasome & viva (data not shown) and inhibits ubiquitin-mediated protein degradation, which occurs via the proteasome, in w&o and in viva ([ 14, 151, and J Hagler, 0 Rando, GF, SLS & T Maniatis, unpublished data) . There is an excellent correlation between the ability of a series of analogs of lactacystin to compete with radiolabeled lactacystin for binding to the proteasome, inhibiting its funcdon and their ability to induce neurice outgrowth in Nemo 2A cells [2, 7] . Furthermore, lactacystin appears to be highly specific for the proteasomc, since no other procease tested, including trypsin, chymotrypsin, papain, calpain and cachcpsin B [7] , thrombin and plasminogen activator [l] , has been inhibited by lactacystin. it also does not inhibit lysosomal protein degradation 1151. Lactacystin is unique in terms of its proteasome specificity and, as a result, has become a widely used probe of proteasome function.
T'he rates of inhibition of the chymotrypsin-like, trypsinlike and PGPH activities of the 205 proteasome by lacracystin arc significantly different, and only the two most rapidly inhibited activities, chymotrypsin-like and trypsinlike, are irreversibly inhibited [7] . The chymotrypsin-like activity is inhibited -20 times faster than the trypsin-like activity (and -50 times faster than the PGPH activity). A @-&tone related to lactacystin, &J&J-lactacystin P-lactone, formally the product of elimination of N-acetylcysteine from lactacystin, is 15-20 times more potent as an inhibitor of all three peptidsse activities than lactacysdn, yet is just as specific for the proteasome as is lactacystin [7] . The effects of lactacystin appear to be mediated through formation of the P-lactone as an active intermediate [lb] .
In 205 proceasome purified from bovine brain, the timeframe of inhibition of the two irreversibly inhibited acrivities is correlated with binding to one proccasome subunit, subunit X (also known as MB]. or E), with which lactacystin forms a stable covalent complex in a 21 1actacystin:protein stoichiometry [7] . Lactacystin modifies the putatively catalytic amino-terminal threonine of the mature, proteolyrically processed subunit X, as we11 as an internal residue 171. Lactacystin also binds to a second proteasome subunit containing chreonine at the amino terminus, now known as subunit % (or MC14), in bovine brain proteasome preparations: however, binding to this second subunit occurs too slowly to account for inhibition of the chymotrypsin-like and trypsin-like activities, and there is no evidence that the amino-terminal threonine of this secondary lactacyscinbinding protein is modified by lectacystin [7] .
Studies in other systems provide further evidence that proteasome subunit X and its homologs may have a catalytic role. Subunits X and Z are P-type proceasome subunits, so termed because they are related to the P-subunit of the 205 proteasome from the archaeon T&mopEu~rna Lscidop/siluna. The T. ucidopAi~tim proteasome's autocatalytically processed P-subunit has an amino-terminal threonine that is critical for activity [17] . The X-ray crystal structure of the T. ac&p&lum proteasome with bound peptide aldehyde inhibitor also suggests that this residue is part of the active site and chat the sidechain hydroxyl may be involved in nuclcophilic attack on the amide carbonyl carbon of peptide substrates [18] . The yeast homolog of subunit X, PreZ, has an aminoterminal threonine as well, and this subunit is required for chymotrypsin-like activity and the degradation of ubiquitinated proteins 1191. The proteasome is therefore a member of the recently recognized amino-terminal nucleophile hydrolase family of proteins. These proteins all appear to be processed from precursor proteins to generate amino-terminal nucleophilic residues (threoninc, serine or cysteine) and to have a similar fold in the activesite region, providing the capacity for nucleophilic attack and the possibihty for autocatalytic processing It is now well established that the proteasome is involved in the generation of antigens for class I major histocompatibility (MAC) presentation, and that two proteasome suhunits encoded in the class II MHC region, LMP7 (a closely related homolog of subunit X) and LMPZ (related to another subunit termed Y or S), may be important in the immune response (for reviews, see [9, 10, 23] ). Mice with a targeted deletion of LMP7 exhibit reduced levels of MI-IC class I expression at the cell surface and inefficient antigen presentation 1241. LMPZ appears to be needed for presentation of certain class I MI-IC antigens to cytotoxic T lymphocytes [ZS] . Treatment of mammalian cells with yinterferon alters the peptidase activities of the pruteasome [Z&29] and results in down-regulation of subunits X and Y and up-regulation of LMP7 and LMPZ [3O-321. A similar reciprocal relationship also exists between subunit 2 and the r&red y-interferon-inducible subunit MECLl (also known as LMPlO) [33, 34] . 'These results imply chat LMPZ and LMP7 (and possibly MECL1) are partly responsible for optimizing the proteasome for generation of antigenic peptides for class I MHC presentation by inducibly taking over the roles of their normally expressed cognates, Lactacystin-binding subunits It has recently been shown that, in addition to subunits X and 2, four other P-type subunits, Y, LMPZ, LMP7 and MECLl, all of which have a threonine at their aminoterminus, are capable of binding lactacystin in lymphobiast cells 1151, although there is as yet no evidence to suggest that the amino-terminal threonine residues of these other subunits are covalently modified. Therefore, six putatively catalytic proteasome subunits, falling into three groups of related and reciprocally regulated subunits, appear to be able to bind lactacystin, and none of the other subunits of the proteasome bind lactacystin [7, 15] .
Lacracystin is uniquely specific for the pruteasome versus other proteases; however, it inhibits multiple proteasome peptidase activities [7] . In an attempt ro determine which of the peptidase activities of the proteasome needs to be inhibited to induce a bipolar morphology in Neuro 2A cells,
we created cells with cell-permeable peptide aldehydes that inhihit subsets of the proteasome's peptidase activities. We found that treatment with inhibitors ending in hydrophobic residues resulted in bipolar-type neurite outgrowth that was very similar to chat induced by lactacystin, while treatment with an inhibitor of the trypsin-like activity did not result in any deccctable difference in morphology from untreated control cells. One of the inhibitors tested and found to induce neurite outgrowth, N-benzyloxycarbonylleucine-leucine-phenylalnninal (Z-LLFal), has been previously shown to inhibit the chymotrypsin-like activity of the --_ & Biology (Figs 2b,3) , in which two neurites extend from opposite sides of the cell body. The cells become progressively more multipolar with prolonged exposure to these peptide aldehydes as with lactacystin ( Fig. Zc) , while the proportion of unipolar cells in each case is low at every .time point (Fig. Za) . The morphology induced by treatment with Z-LLFal (or by Ac-LLnLal or Ac-1,LMal) is indistinguishable from that induced by lactacystin (Fig. 3) .
In contrast, treatment with leupeptin, which inhibits the trypsin-like activity of the proteasome without inhibiting Figure  3 any of its other pepcidase activities [13, 37, 38] , does not lead to any detectable difference in cell morphology from untreated control cells even at the elevared concentration of 1 mM (Figs 2,3) . Although it is not clear at this point how important the nypsin-like activity of the protcasomc is in determining overall rates of protein breakdown, our results show that inhihition of rhis activity -whatever its normal physiological function -does not result in neurice outgrowth. Furthermore, since leupeptin inhibits the cytosolic proteasc calpain [39] and many extracellular and lysosomal proteases [41, 42] , it is unlikely that inhibition of such proteases could mediate the induction of bipolar-type neurice outgrowth in Ncuro 2A cells.
Inhibition of the chymotrypsin-like activity of the proteasome, without inhibition of the ocher two neutral amino acid preferring activities, appears to be sufficient to induce neurite outgrowth in Neuro 2A cells, since Z-LLFal inhibits only the chymotrypsin-like activity of the three neutral amino acid preferring activities [13] . Z-LLFal does The length of the bars corresponds to 100 pm.
nor inhibit The PGPH activity and significancly inhibits the trypsin-like activity only at elevated concentrations [35] , while treatment with leupepcin, which only inhibits the crypsin-like activity of the proteasome's activities, does not lead to neurite outgrowth (Figs 2,3 ). Taken together with previous results using the proteasome-specific inhibitor lactacystin [.2,7] , these results imply char. inhibition of the chymocrypsin-like activity is responsible for the neurite outgrowth that results from proteasome inhibition. Since ir appears not to be necessary to inhibit the other peptidase activities of the proteasome for neurice outgrowth to occur, only the chymotrypsin-like activity appears co antagonize neurite outgrowth.
Z-LLFal is the most potent inducer of neurite outgrowth on the basis of the concentration required for activity, followed by Ac-LL,nLal and then Ac-LLMal ( Fig. 2  and data not shown) . This order of effectiveness also corresponds to the order of potency of these peptide aldehydes for inhibition of the proteasome's chymotrypsin-like activity [3.5,36] . Since the more potent inducers of ncurite outgrowth are also the more potent inhibitors of the chymotrypsin-like activity, the neuritogenie potency of a peptide aldehyde may be determined by its effectiveness as an inhibitor of the proceasomc's chymotrypsin-like acriviry.
Relevance of the cellular response Bipolar-type neurite outgrowth in response to lactacystin or the peptide aldehydes ending in hydrophobic residues does not appear to be a non-specific cellular response to stress. Treatment of Neuro 2A cells with cytotoxic concentrations of various compounds leads to rounding up of cells and ultimately to detachment from the substratum without any induction of bipolar inorphology at any point (data not shown). Although elevated concentrations of lactacystin and the neuritogenically active peptide aldehydes are cytotoxic, lower concentrations sufficient to induce bipolar morphology do not result in rounding up and death of cells (Fig. 2 and data not  shown) . In contrast, sub-cytotoxic concentrations of a variety of other growth-inhibitory compounds do not result in bipolar-type neurite outgrowth (data not shown). Lactacystin and the neuritogenically active peptide aldehydcs examined are alone among inhibitors of cell pruliferation and inducers of differentiation in that treatment results in a mainly bipolar type of neurite outgrowth.
While inhibition of the chymotrypsin-like activity of the proteasome may represent a specific and limited kind of cellular stress, the response of the ceils is unique in terms of the predominant morphology induced.
It is therefore reasonable to assume that the chymotrypsin-like activity of the proreasome is required either to destroy a protein that directly 'or indirectly promotes neurite outgrowth, or to activate a protein that antagonizes neurire outgrowth.
Two of the peptide aldehydes that induce neurice outgrowth, Ac-LLnLal and Ac-LLMal, have also been shown to inhibit cnrhepsin B and calpain [36] . Lactacystin, however, inhibits neither of these proteases [7] . It is, of course, possible that bipolar-type neurice outgrowth in response co the peptide aldchydes occurs by a different mechanism rhan with lactacystin. But as the observations show that the morphology of the cells rreaced with these compounds is comparable to that of cells treated with lactacystin, and as neuritogenic potency of these compounds correlates with their ability to inhibit the proteasome's chymotrypsin-like activity, it seems more likely that the mechanism involved is similar.
Certain rripeptide aldehydes, including N-benzyloxycarbonyl-Leu-Lcu-leucinal (Z-LLLal), induce neurite outgrowth in PC12 rat pheochromocytoma cells, and purification of the N-benzyloxycarhonyl-Leu-Leu-Leu-7-amido-4-methylcoumarin-degrading activity reveals that the proteasome is the main target [43] . Lactacystio, however, does not have any detectable neuritogenic effect on PC12 cells but does exhibit a dose-dependent toxic effect [Z] . It is thtircfore possible that the actual targer that mediates neurite outgrowth in PC12 cells in response to Z-LLLal is a proteasc other than the protcasome. It is also possible chat lactacystin, though uniquely specific for the proteasome versus other proteases, may inhibit a broader range of the proteasome's peptidase activities than does Z-LLLal.
For example, if the proteasome normally activates a protein that antagonizes neurite outgrowth, a second proteasome activity might be required in PC12 cells CO ensure its continued activity. If both activities are inhibited by lactacystin, but only the first is inhibited by Z-LLLal, then Z-LLLal, but not lactacystin, would induce neurite outgrowth in these cells.
Inhibition of the proteasome's chymotrypsin-like activity may promote bipolar neurite outgrowth in Neuro ZA cells by either preventing the degradation of a protein that promotes bipolar neurite outgrowth OF preventing the proceolytic activation of a protein that antagonizes bipolar neurite outgrowth. The results presented here suggest that the chymotrypsin-like activity is involved, direcdy or indirectly, in the degradation or proteolytic activation of the putative substrate(s) of the proteasornc that either positively or negatively regulates the induction of a bipolar morphology, There are two simple explanations for the importance of the chymotrypsin-like activity in the regularion of neurite outgrowth, although more complicated models can also be envisioned. The chymorrypsinlike activity may be solely responsible for the relevant cleavage of the substrate, most plausibly leading to an activation of the substrate's function. Alternatively, the chymotrypsin-like protease activity may be required for the first step in the processive degradation of the substrate involved in neurite outgrowth. In the first case, it is the 
